Jun Jiang
Impact in
- Cancer Research top 2%
- Breast Cancer Treatment Studies
- Oncology top 2%
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Breast Cancer Treatment Studies 42
- Oncology 50
- HER2/EGFR in Cancer Research 10
- Cancer Immunotherapy and Biomarkers 9
- Co-authors
- Xiaowei Qi (39 shared papers)Bangping Qian (23 shared papers)Linjun Fan (31 shared papers)Minghao Wang (22 shared papers)Bin Wang (18 shared papers)Yaqing Chen (11 shared papers)Yong Qiu (13 shared papers)Saihu Mao (12 shared papers)
- Journals
- Spine (11 papers)European Spine Journal (8 papers)Scientific Reports (7 papers)PLoS ONE (6 papers)Annals of Oncology (5 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Jun Jiang
289 papers receiving 5.7k citations
Peers
Comparison fields: 5 of 134
- Cancer Research 861
- Oncology 996
- Gastroenterology 206
- Surgery 1k
- Immunology 430
Countries citing papers authored by Jun Jiang
This map shows the geographic impact of Jun Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Jiang more than expected).
Fields of papers citing papers by Jun Jiang
This network shows the impact of papers produced by Jun Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Jiang. The network helps show where Jun Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 306 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 184 | |
| 2 | 2017 | 182 | |
| 3 | 2015 | 144 | |
| 4 | 2018 | 123 | |
| 5 | Mechanism, safety and efficacy of three tyrosine kinase inhibitors lapatinib, neratinib and pyrotinib in HER2-positive breast cancer. | 2019 | 119 |
| 6 | 2018 | 114 | |
| 7 | 2018 | 106 | |
| 8 | 2017 | 98 | |
| 9 | 2023 | 98 | |
| 10 | 2017 | 97 | |
| 11 | 2015 | 96 | |
| 12 | 2010 | 92 | |
| 13 | 2019 | 91 | |
| 14 | 2018 | 81 | |
| 15 | 2008 | 77 | |
| 16 | 2020 | 77 | |
| 17 | 2012 | 75 | |
| 18 | 2016 | 75 | |
| 19 | 2011 | 72 | |
| 20 | 2009 | 61 |
About Jun Jiang
Jun Jiang is a scholar working on Cancer Research, Oncology, Surgery, Gastroenterology and Pathology and Forensic Medicine, having authored 306 papers that have together received 5.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (42 papers), Scoliosis diagnosis and treatment (34 papers), Breast Lesions and Carcinomas (15 papers), Gastrointestinal motility and disorders (14 papers), Breast Implant and Reconstruction (11 papers), HER2/EGFR in Cancer Research (10 papers), Thyroid and Parathyroid Surgery (10 papers) and Cancer Immunotherapy and Biomarkers (9 papers). The work is most often cited by research in Cancer Research (861 citations), Oncology (996 citations), Gastroenterology (206 citations), Surgery (1k citations) and Immunology (430 citations). Jun Jiang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Xiaowei Qi, Bangping Qian, Linjun Fan, Minghao Wang, Bin Wang, Yaqing Chen, Yong Qiu, Saihu Mao, Xinhua Yang and Yi Zhang. Their work appears in journals such as Spine, European Spine Journal, Scientific Reports, PLoS ONE and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.